Search results
Added:
1 year ago
Added:
6 months ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;…
View more
Added:
1 year ago
EuroPCR 23 - Join us as we discover the latest findings from a three-year follow-up of the EBC MAIN Trial, as we interview Principal Investigator Dr David Hildick-Smith (Brighton and Sussex University Hospitals, UK) onsite at EuroPCR 23.
The EBC Main Trial aimed to investigate the outcomes of single-stent versus dual-stent bifurcation treatment of distal left main coronary artery lesions. This…
View more
Added:
1 year ago
In this video series, first presented at the ESC Congress 2023 held in Amsterdam, Prof Roxana Mehran, Dr Antoinette Neylon, Dr Martin Swaans, Prof Raphael Rosenhek and Prof Haim Danenberg discuss the Expand II TAVR pivotal trial design and the rational for investigating the treatment of moderate aortic stenosis patients with Evolut™ TAVI, provide practical Echo imaging recommendations to improve…
View more
Added:
2 weeks ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego…
View more
Added:
1 year ago
Added:
1 year ago
Added:
1 year ago
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This randomized controlled, multi-center trial aimed to investigate whether transcatheter aortic valve implantation (TAVI) is non-inferior to surgical aortic valve replacement (SAVR) in patients with symptomatic severe…
View more
Added:
2 months ago
CRT 25 - Insights on the progression risk in patients with mild to moderate aortic stenosis (AS) show that there was no significant difference in progression rates between mild and moderate AS. However, moderate AS patients had significantly higher mortality rates than mild AS patients at one- and two-year follow ups. The study also suggests that elevated phosphate levels and elevated…
View more
Added:
11 months ago
EuroPCR 24 - We are joined onsite by Prof Ole De Backer (Rigshospitalet, DK) to discuss the findings from the NOTION-2 Study. (NCT02825134).NOTION-2 is a randomized, multicenter trial which aimed to investigate transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in 376 patients under 75 years of age with severe aortic valve stenosis in regard to intra-…
View more
